Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2024 | Story Anthony Mthembu | Photo Sanchay Kalicharan
EMS research symposium 2024
Pictured at the research symposium from left to right: Cornelle Scheltema-Van Wyk, Deputy Director at the Library and Information Services at UFS; Prof Lochner Marais, Professor at the Centre for Development Support at UFS; Prof Brownhilder Neneh, Vice-Dean: Research, Engagement and Internationalisation in the EMS faculty at UFS; Prof Nicolene Barkhuizen, Director of the Business School at UFS; Prof Betty Mubangizi, Professor from the University of Kwa-Zulu Natal; and Prof Phillipe Burger, Dean of the EMS faculty at UFS.

The Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS) recently hosted a transformative research career development symposium on 24 April 2024 and 3 May 2024 at the UFS Business School, on the Bloemfontein Campus. Themed “Building the Next Generation of Researchers and Academics: developing a Body of Work within a Niche Area and Publishing in Quality Journals,” the symposium provided a pivotal platform for scholarly growth and strategic planning.

In his opening address, Prof Philippe Burger, the Dean of the EMS faculty, underscored the significance of the event, stating, “We need to be scholars who can be contacted from outside and be ambitious to be known for something; this symposium would give our staff that opportunity.”

Symposium highlights

Prof Brownhilder Neneh, Vice-Dean of Research, Engagement and Internationalisation in the EMS faculty, elucidated the symposium’s objectives, highlighting its role in fostering career development, equipping lecturers with practical insights, and fostering proactive career management. Distinguished guests from institutions nationwide graced the symposium with their expertise.

The first session, tailored for the School of Accountancy, featured luminaries in the accounting field such as Prof Elmar Venter from the University of Pretoria (UP) and Professor Belinda Le Clerq from the University of South Africa (UNISA). The subsequent session catered to lecturers and senior lecturers across the faculty, featuring presentations from esteemed academics like Prof Mercy Mpinganjira from the University of Johannesburg (UJ), Prof Sebastian (Ian) Rothmann from the North-West University (NWU), and Prof Betty Mubangizi from the University of KwaZulu Natal (UKZN). Internal speakers, including Prof Burger, Prof Lochner Marais from the Centre for Development Support (CDS) at the UFS, and Prof Nicolene Barkhuizen, Director of the Business School at the UFS, also shared insights.

Symposium value and alignment with Vision 130

Prof Neneh stressed the symposium’s alignment with Vision130. She said, ‘’Hosting this symposium demonstrates the faculty’s commitment to nurturing a research-led faculty that not only addresses local and regional problems but aligns with international standards. Prof Neneh noted that the engagement offered an invaluable opportunity for academic staff to deepen their understanding of research niche areas, the significance of publishing in high-impact journals, and the cultivation of sustainable research networks.

Throughout the symposium, presenters covered a diverse array of topics, including identifying and refining niche research areas, best practices for conducting high-impact research, overcoming publishing challenges, and strategies for enhancing visibility and citation impact.  

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept